Today, We introduced the G-Rex grants at the ISCT Vancouver. Our COO Ignacio Núñez talks about sustainability, industry trends and grant’s eligibility criteria. https://lnkd.in/gbjQbavE
CellReady™
Biotechnology Research
Houston, TX 1,141 followers
We create hope for Patients, one G-Rex at a time
About us
CellReady is specifically designed to cut two years, and millions of dollars, off the path that cell and gene therapy (CGT) companies take to acquire the meaningful clinical inflection points that investors demand. CGT companies are funded by investors that expect to see their money generate meaningful clinical data before they make additional investments. But that rarely happens. Instead of spending the money on clinical data, CGT companies burn through 5%-10% of their investor's money each month while they struggle to create the essential building blocks of their CGT company, such as a quality management system, scalable manufacturing process, and a CMC section that is sure to clear FDA scrutiny. The CGT industry now faces a crisis. Investors no longer tolerate this time-consuming approach that leaves them empty handed. CellReady solves the problem by allowing CGT companies to hit the ground running with all of the essential building blocks they need to quickly gather meaningful clinical data. And CellReady is not driven solely by profit. CellReady will provide CGT companies with an optimized, scalable, and standardized G-Rex centric cell manufacturing process at virtually no charge, a nimble quality management system for free, ready-made sections of the CMC that will clear FDA review, and a vast array of expertise in all technical and business aspects of running a successful CGT company.
- Website
-
www.wilsonwolf.com
External link for CellReady™
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Houston, TX
- Type
- Privately Held
- Founded
- 2023
Locations
-
Primary
Get directions
4551 Kennedy Commerce Drive
Houston, TX 77032, US
-
Get directions
2100 OLD HIGHWAY 8 NW
New Brighton, MN 55112, US
-
Get directions
9350 Kirby Drive
Houston, TX 77054, US
Employees at CellReady™
-
John Wilson
Wilson Wolf CEO focused on solving cell and gene therapy manufacturing challenges
-
Ignacio Núñez
Chief Operations Officer at CellReady™
-
Tara Shahim
Principal Scientist @ CellReady™ | Closed System Cell Therapy Development
-
Eric Smith, Ph.D.
Assay/Product Development | Cell & Gene Therapy | Cell Engineering
Updates
-
CellReady™ reposted this
We are happy to report that Applied Cells, specializing in cell separation, informed us that they will be joining the G-Rex Grant Program and joining our legion of likeminded collaborators Wilson Wolf Manufacturing, LLC, Bio-Techne, CellReady™, Akadeum Life Sciences, Inc., MaxCyte, Inc., and Vector BioMed, Inc. 👏
We’ve been eager to let you know about the rollout of a $20 million G-Rex Grant Program which goes live today and is accessible to every cell and gene therapy entity that is moving toward, or already conducting, clinical manufacturing. The program goal is to ensure that every recipient is able to establish the most cost effective manufacture of clinical products in the shortest amount of time. To meet that goal, the G-Rex Grant Program includes a wide range of essential products, services, and expertise that will all be made available to recipients. We hope that academic entities and private companies will take advantage of this program. It’s open to all, designed to be very easy to use, and we’re confident that every participant will find it highly beneficial. This program is possible thanks to the participation of forward-thinking collaborators who are dedicated to making a meaningful impact in the field of cell and gene therapy, including Wilson Wolf Manufacturing, LLC, Bio-Techne, CellReady™, Akadeum Life Sciences, Inc., MaxCyte, Inc., and Vector BioMed, Inc. If there are other like-minded entities that have the ability to help propel our goal, please don’t hesitate to reach out to us. We’d also kindly request that people seeing this message repost it so that it reaches the broadest audience possible. You can learn more about how easy it is to become a recipient of a G-Rex Grant here: https://lnkd.in/eWesmsWJ #cellandgenetherapy #GRex #innovation #collaboration
-
CellReady™ reposted this
We’ve been eager to let you know about the rollout of a $20 million G-Rex Grant Program which goes live today and is accessible to every cell and gene therapy entity that is moving toward, or already conducting, clinical manufacturing. The program goal is to ensure that every recipient is able to establish the most cost effective manufacture of clinical products in the shortest amount of time. To meet that goal, the G-Rex Grant Program includes a wide range of essential products, services, and expertise that will all be made available to recipients. We hope that academic entities and private companies will take advantage of this program. It’s open to all, designed to be very easy to use, and we’re confident that every participant will find it highly beneficial. This program is possible thanks to the participation of forward-thinking collaborators who are dedicated to making a meaningful impact in the field of cell and gene therapy, including Wilson Wolf Manufacturing, LLC, Bio-Techne, CellReady™, Akadeum Life Sciences, Inc., MaxCyte, Inc., and Vector BioMed, Inc. If there are other like-minded entities that have the ability to help propel our goal, please don’t hesitate to reach out to us. We’d also kindly request that people seeing this message repost it so that it reaches the broadest audience possible. You can learn more about how easy it is to become a recipient of a G-Rex Grant here: https://lnkd.in/eWesmsWJ #cellandgenetherapy #GRex #innovation #collaboration
ScaleReady Announces $20 Million G-Rex® Grant Program for the Advancement of Cell and Gene Therapy (CGT) Development and Manufacturing
prnewswire.com
-
Our COO, Ignacio Núñez talks about the continuous improvement paradigm shift coming to Cell Therapy
Can we make CAR-T like we make cars? At this month's ASGCT annual meeting in Baltimore, we caught up with CellReady™'s Ignacio Núñez to discuss what the industry needs to do to achieve this. To see more of our interviews, including more from American Society of Gene & Cell Therapy's annual meeting, visit https://www.ibcomms.tv/ Special thanks to Rebecca Louise Price and ScaleReady #CGTmanufacturing #ASGCT2024
Ignacio Nunez - CellReady - ASGCT24
https://www.youtube.com/
-
Make sure you save yourself a seat at the highly anticipated presentation from our COO, Ignacio Núñez , on May 8th at 4pm on behalf of ScaleReady. Ignacio will present, “Revolutionizing CAR-T Cell Production: Can we make CAR-Ts like we make CARS?" 🤔 The presentation will be a high-level introduction to topics such as regulatory challenges and quality assurance in cell therapy, ensuring compliance while optimizing throughput and flexibility. We will see you there! RSVP and add to your calendar here >>>> https://lnkd.in/e_JyGzT6 #ASGCT #ASGCT2024 #celltherapy #cellmanufacturing #cellandgenetherapy
-
-
We’re #hiring a new Cell Therapy GMP Specialist I, II, III in Houston, Texas. Apply today or share this post with your network.
-
Join our COO, Ignacio Núñez, for a groundbreaking presentation on the successful manufacturing of half a trillion NK cells! CellReady was able to unlock this achievement by leveraging existing manufacturing technology utilized by many commercialized cell therapy drugs today! Attend our talk: “NK potential unlocked! Half a trillion cells in 20 days” on March 19th at 12:30 pm in San Diego to learn how your NK cell therapy program can replicate and achieve the same results! Save your spot here >>>> https://lnkd.in/eyFHm63W #innatekillersummit #innatekiller #NK #celltherapy #cellmanufacturing
-
CellReady™ reposted this
Let's talk about G-Rex performance. https://lnkd.in/gBixdZUv
-